Oncotarget: Indoximod opposes the immunosuppressive effects mediated by IDO and TDO Bioengineer, 23 Jun 2020 Volume 11 Issue 25 of Oncotarget reported that Indoximod has shaped the understanding of the biology of IDO1 in the control of…